TYRA
Tyra Biosciences, Inc.NASDAQHealthcare$39.61+3.47%ClosedMarket Cap: $2.13B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
8.95
P/S
0.00
EV/EBITDA
-16.91
DCF Value
$1.18
FCF Yield
-4.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-41.2%
ROA
-42.4%
ROIC
-50.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-36.5M | $-33.8M | $-0.57 | — |
| FY 2025 | $0.00 | -Infinity% | $-132.8M | $-119.9M | $-2.01 | — |
| Q3 2025 | $0.00 | NaN% | $-32.9M | $-29.9M | $-0.50 | — |
| Q2 2025 | $0.00 | NaN% | $-31.5M | $-28.1M | $-0.47 | — |
| Q1 2025 | $0.00 | NaN% | $-31.9M | $-28.1M | $-0.47 | — |
| Q4 2024 | $0.00 | NaN% | $-29.7M | $-25.6M | $-0.43 | — |
| FY 2024 | $0.00 | NaN% | $-104.2M | $-86.5M | $-1.51 | — |
| Q3 2024 | $0.00 | NaN% | $-28.6M | $-24.0M | $-0.41 | — |
| Q2 2024 | $0.00 | -Infinity% | $-23.5M | $-18.7M | $-0.32 | — |
| Q1 2024 | $0.00 | -Infinity% | $-22.3M | $-18.2M | $-0.35 | — |
| Q4 2023 | $0.00 | NaN% | $-25.6M | $-22.8M | $-0.53 | — |
| FY 2023 | $0.00 | NaN% | $-79.9M | $-69.1M | $-1.62 | — |